The COBRE Center for Studies of Host Response to Cancer Therapy is directed by Martin Hauer-Jensen, MD PhD. Dr. Hauer-Jensen’s research focuses on cancer survivorship issues, particularly on how to make radiation therapy more tolerable, safer, and more effective, and on development of medical countermeasures against radiological/nuclear accidents or terrorism. Dr. Hauer-Jensen has published more than 200 peer reviewed scientific articles and book chapters. His research has received support from the American Cancer Society, Veterans Administration, National Cancer Institute (NCI), National Institute of Allergy and Infectious Disease (NIAID), Defense Threat Reduction Agency (DTRA) of the Department of Defense, and Biomedical Advanced Research and Development Authority (BARDA). He serves on several national and international peer review panels, task forces, and advisory boards. He was recently chairman of the Radiation Therapeutics and Biology Study Section, the panel that reviews radiation-related projects submitted to the National Institutes of Health (NIH).